Cliff Asness’s Pfizer PFE Stock Holding History

Cliff Asness’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-42,476	Closed	-$28M	–	2521
2013 Q2	$28M	Buy	+42,476	New	+$1.17M	0.1%	255

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cliff Asness's PFE Position: Q2 2026 in Review

Cliff Asness increased its Pfizer (PFE) stake by 56% in Q2 2026, buying an estimated $175M and bringing the position to 18,557,891 shares worth $445M. The position accounts for 0.16% of the portfolio, ranked #160.

Cliff Asness first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.19B in Q4 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Cliff Asness held 18,557,891 shares of Pfizer worth $445M as of Q2 2026.
Cliff Asness bought 6,678,656 Pfizer shares in Q2 2026, an estimated $175M.
Pfizer made up 0.16% of Cliff Asness's portfolio in Q2 2026, its #160 holding.
Cliff Asness first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Cliff Asness's Pfizer position peaked at $1.19B in Q4 2018.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.